Indication

Peptostreptococcus osteomyelitis

*Peptostreptococcus* osteomyelitis is an infectious inflammatory condition of the bone and bone marrow caused by anaerobic, Gram-positive cocci belonging to the genus *Peptostreptococcus*. Read more about Peptostreptococcus osteomyelitis

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Peptostreptococcus osteomyelitis therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Peptostreptococcus osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Peptostreptococcus osteomyelitis.

*Peptostreptococcus* osteomyelitis is an infectious inflammatory condition of the bone and bone marrow caused by anaerobic, Gram-positive cocci belonging to the genus *Peptostreptococcus*.

It predominantly affects adults with predisposing factors such as diabetes mellitus, peripheral vascular disease, compromised immunity, or following surgical procedures, trauma, and periodontal disease.

Pathophysiologically, the infection typically arises from contiguous spread from adjacent soft tissue ulcers or sinus tracts, direct traumatic or surgical inoculation, or occasionally via hematogenous seeding to structures such as the vertebrae, mandible, feet, or pelvis.

It frequently presents within polymicrobial anaerobic environments and is clinically characterized by localized bone pain, swelling, erythema, chronic purulent drainage, and progressive cortical bone destruction or sequestrum formation.

Personalize your experience

Follow Peptostreptococcus osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it